LIBERTY PARTNERS GROUP, LLC

Lobbying for ANGIOSAFE (CARDIOVASCULAR COALITION) · Manufacturer of products to treat peripheral artery disease.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · posted Jul 20, 2026

Lobbying activity 2

Medicare/Medicaid

Physician payment and policy issues related to peripheral arterial disease and other cardiovascular issues.

Health Issues

Physician payment and policy issues related to peripheral arterial disease and other cardiovascular issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.